Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

    loading  Checking for direct PDF access through Ovid

Abstract

New corticotropin releasing factor (CRF) antagonists in irritable bowel disease (IBS) warrant testing, and CRF1 receptors may be a promising target for the treatment of IBS

Related Topics

    loading  Loading Related Articles